An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus
Abstract Hydroxychloroquine (HCQ) use is indicated for patients with systemic lupus erythematosus (SLE). Nevertheless, reports discussing the reasons for not prescribing HCQ are limited. We identified the factors that interfere with HCQ use in patients with SLE. This observational, single-center stu...
Main Authors: | Atsushi Manabe, Ryuichi Minoda Sada, Hirofumi Miyake, Hiroyuki Akebo, Yukio Tsugihashi, Kazuhiro Hatta |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-04-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-58463-3 |
Similar Items
-
Author Correction: An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus
by: Atsushi Manabe, et al.
Published: (2024-06-01) -
New onset bullous lupus erythematosus in a systemic lupus erythematosus patient after initiation of hydroxychloroquin
by: Chanchal Gera, et al.
Published: (2014-01-01) -
Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
by: Noël Zahr, et al.
Published: (2021-03-01) -
New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre
by: Rahana Abd Rahman, et al.
Published: (2020-12-01) -
Advancements on the impact of hydroxychloroquine in systemic lupus erythematosus
by: Liu Peng-Cheng, et al.
Published: (2024-05-01)